NCT06296784

Brief Summary

This study aims to present data on the improvement of Quality of life (QoL), biological rhythms, anxiety, depressive symptoms and the correlations between QoL and biorhythms following an e-health psychoeducational intervention for Bipolar Disoirder (BD) during Covid-19 pandemic

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 26, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2021

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

February 29, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
Last Updated

April 5, 2024

Status Verified

April 1, 2024

Enrollment Period

6 months

First QC Date

February 29, 2024

Last Update Submit

April 4, 2024

Conditions

Keywords

Bipolar DisorderPsychoeducationCOVID-19 Pandemic

Outcome Measures

Primary Outcomes (4)

  • Generalized Anxiety Disorder (GAD-7)

    GAD-7 is 7 item self-administered questionnaire evaluates symptoms of an anxiety disorder

    T0 (0 weeks); T1 (8 weeks); T2 (16 weeks)

  • Hamilton Depression Rating Scale (HDRS21)

    Depressive symptoms were assessed using HDRS21 consists of 21 items, and the total score allows for the assignment of severity scores for the symptoms

    T0 (0 weeks); T1 (8 weeks); T2 (16 weeks)

  • Short Form Health Survey (SF-12)

    SF12 is a self-administered questionnaire consisting of 12 items that assess two dimensions: physical health and mental health to establish poor/good QoL.

    T0 (0 weeks); T1 (8 weeks); T2 (16 weeks)

  • Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN)

    BRIAN is a interview consisting of 18 items that investigate four main areas related to the dysregulation of biological rhythms: sleeping, activity, social rhythms, and eating.

    T0 (0 weeks); T1 (8 weeks); T2 (16 weeks)

Study Arms (2)

e-health psychoeducation

EXPERIMENTAL
Other: e-health psychoeducation

waiting list

NO INTERVENTION

Interventions

e-health psychoeducation intervention provides information about BD clinical condition and symptoms, as well as identifying effective coping strategies to manage symptoms and the dysregulation of biological rhythms. The content covered the impact of the pandemic and its related restrictions on mental health, particularly on anxiety and depressive symptoms. The intervention comprised one session per week for two months, and each session lasted approximately an hour and a half. It was conducted by healthcare professionals.

e-health psychoeducation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of BD according to DSM-V, over 18 years old

You may not qualify if:

  • do not have bipolar disorder, refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Giovanni di Dio Hospital

Cagliari, CA, 09100, Italy

Location

MeSH Terms

Conditions

Bipolar DisorderCOVID-19

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Open-label cross-over randomized controlled trial (two arms)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 29, 2024

First Posted

March 6, 2024

Study Start

May 26, 2021

Primary Completion

November 15, 2021

Study Completion

November 15, 2021

Last Updated

April 5, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations